Steve Elms

Insider Reports History

Entity
Individual
Location
888 Seventh Ave, 29 Th Fl, New York, NY
Signature
/s/ Steve Elms, by Michael A. Goldstein as Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Steve Elms:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ADMA BIOLOGICS, INC. Director Common Stock 2.12M $22.9M $10.80 Nov 27, 2024 Indirect
ADMA BIOLOGICS, INC. Director Common Stock 76.4K $826K $10.80 Nov 27, 2024 Direct
ADMA BIOLOGICS, INC. Director Stock Option (Right to Buy) 0 $0 $3.66 Nov 27, 2024 Direct
Zosano Pharma Corp Director Common Stock 2.72M Jun 10, 2021 (2)
Elevation Oncology, Inc. Director Stock Option (Right to Buy) 35K Jun 13, 2024 Indirect
Zosano Pharma Corp Director Stock Option (Right to Buy) 30K Jun 10, 2021 Direct
Zosano Pharma Corp Director Common Stock 22.5K Jun 10, 2021 Direct
Marker Therapeutics, Inc. Director Stock Option (right to buy) 8K Jun 6, 2023 Direct

Insider Reports Filed by Steve Elms

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ADMA ADMA BIOLOGICS, INC. Nov 27, 2024 2 $97.2K 4 Dec 2, 2024 Director
ELEV Elevation Oncology, Inc. Jun 13, 2024 1 $0 4 Jun 17, 2024 Director
ADMA ADMA BIOLOGICS, INC. Mar 18, 2024 2 -$2.8M 4 Mar 19, 2024 Director
ADMA ADMA BIOLOGICS, INC. Mar 13, 2024 3 -$6.34M 4 Mar 15, 2024 Director
ADMA ADMA BIOLOGICS, INC. Feb 26, 2024 2 $0 4 Feb 28, 2024 Director
MRKR Marker Therapeutics, Inc. Jun 6, 2023 1 $0 4 Jun 8, 2023 Director
ADMA ADMA BIOLOGICS, INC. Mar 6, 2023 2 $0 4 Mar 8, 2023 Director
MRKR Marker Therapeutics, Inc. May 24, 2022 1 $0 4 May 26, 2022 Director
ADMA ADMA BIOLOGICS, INC. Mar 7, 2022 2 $0 4 Mar 9, 2022 Director
ZSAN Zosano Pharma Corp Jun 10, 2021 2 $0 4 Jun 14, 2021 Director
MRKR Marker Therapeutics, Inc. Jun 8, 2021 1 $0 4 Jun 10, 2021 Director